CLINICAL AND TREATMENT CHARACTERISTICS OF PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) IN EUROPE

被引：0
|
作者：
Oriol, A. [1 ]
Steinmetz, T. [2 ]
Patel, V [3 ]
Kutikova, L. [4 ]
Schmidt, N. [5 ]
Hennies, N. [5 ]
Thiess, A. [5 ]
Kostev, K. [5 ]
Leleu, X. [6 ]
机构：
[1] Hosp Badalona Germans Trias & Pujol, Inst Josep Carreras, Inst Catala Oncol, Barcelona, Spain
[2] MVZ Hematol & Oncol Cologne, Cologne, Germany
[3] Amgen Europe GmbH, London, England
[4] Amgen Europe GmbH, Rotkreuz, Switzerland
[5] IQVIA Commercial GmbH & Co OHG, Frankfurt, Germany
[6] CHU Poitiers, Hosp La Miletrie, Poitiers, France
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN318
引用
收藏
页码：S497 / S498
页数：2
相关论文
共 50 条
  • [21] Real-World Evaluation of Teclistamab for the Treatment of Relapsed/Refractory Multiple Myeloma (RRMM)
    Asoori, Sireesha
    Popat, Rakesh
    Martinez-Lopez, Joaquin
    Kastritis, Efstathios
    Brunaldi, Larissa
    Bansal, Radhika
    Corraes, Andre De Menezes Silva
    Yong, Kwee
    Mactier, Catriona
    Corona, Magdalena
    Saez Marin, Adolfo Jesus
    Fotiou, Despina
    Dimopoulos, Meletios Athanasios
    Chhabra, Saurabh
    Ailawadhi, Sikander
    Parrondo, Ricardo
    Martin, Thomas
    Durie, Brian G. M.
    Lin, Yi
    [J]. BLOOD, 2023, 142
  • [22] Management of Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Treated with Novel Therapies in Routine Clinical Practice in Germany
    Steinmetz, H. Tilman
    Singh, Moushmi
    Milce, Joseph
    Haidar, Mohamad
    Rieth, Achim
    Lebioda, Andrea
    [J]. BLOOD, 2020, 136
  • [23] Daratumumab with Pomalidomide and Dexamethasone at First Relapse in Relapsed and/or Refractory Multiple Myeloma ( RRMM) Patients
    不详
    [J]. BLOOD, 2021, 138
  • [24] PRACTICE PATTERNS AND OUTCOMES IN ELDERLY US PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
    Romanus, D.
    Raju, A.
    Yong, C.
    Seal, B.
    Farrelly, E.
    Labotka, R.
    Jhaveri, M.
    Noga, S.
    Blazer, M.
    Parameswaran, H.
    [J]. HAEMATOLOGICA, 2016, 101 : 532 - 533
  • [25] Efficacy and Safety of Ruxolitinib and Steroids for Treating Patients with Relapsed or Refractory Multiple Myeloma (RRMM)
    Berenson, James R.
    Silagan, Noemi
    To, Jennifer
    Spektor, Tanya M.
    Martinez, Daisy
    Sanchez, Armando J.
    Forouzan, Eli
    Swift, Regina
    Eades, Benjamin
    Schwartz, Gary
    Eshaghian, Shahrooz
    Boccia, Ralph V.
    Yang, Honghao Hank
    Lim, Stephen
    Vescio, Robert
    [J]. BLOOD, 2020, 136
  • [26] Management of patients with Relapsed/Refractory Multiple Myeloma (RRMM) treated with novel therapies in routine clinical practice in Germany
    Steinmetz, T.
    Singh, M.
    Milce, J.
    Haidar, M.
    Rieth, A.
    Lebioda, A.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 177 - 177
  • [27] THE CLINICAL COURSE OF RELAPSED OR REFRACTORY US MULTIPLE MYELOMA (RRMM) PATIENTS RECEIVING TWO OR MORE LINES OF THERAPY
    Romanus, D.
    Raju, A.
    Seal, B.
    Farrelly, E.
    Yong, C.
    Noga, S.
    Jhaveri, M.
    Labotka, R.
    Blazer, M.
    Parameswaran, H.
    [J]. HAEMATOLOGICA, 2016, 101 : 532 - 532
  • [28] A US BUDGET IMPACT MODEL FOR SELINEXOR IN COMBINATION WITH DEXAMETHASONE FOR THE TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM)
    Bassali, J.
    Gould, I
    Mladsi, D. D.
    Kaye, J. A.
    Shah, J.
    Mehta, J.
    [J]. VALUE IN HEALTH, 2020, 23 : S33 - S33
  • [29] A US Budget Impact Model for Selinexor in Combination with Dexamethasone for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma (RRMM)
    Gould, Ian
    Bassali, Jan
    Mehta, Jyotsna
    Shah, Jatin
    Mladsi, Dee Dee
    [J]. BLOOD, 2019, 134
  • [30] Metronomic therapy for heavily pretreated relapsed/refractory multiple myeloma (RRMM).
    Papanikolaou, Xenofon
    Szymonifka, Jackie
    Mitchell, Alan
    Keller, Jason
    Heuck, Christoph Johann
    Waheed, Sarah
    Usmani, Saad Zafar
    Nair, Bijay
    Van Rhee, Frits
    Medlin, Stephen Charles
    Bailey, Clyde
    Petty, Nathan
    Hoering, Antje
    Crowley, John
    Barlogie, Bart
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345